MedPath

Triamcinolone

Generic Name
Triamcinolone
Brand Names
Allernaze, Aristocort, Aristocort R, Juulissa Pharmapak, Kenalog, Kourzeq, Marcaine, Nasacort, Oracort, Oralone, Pediaderm Ta, Triaderm, Trianex, Triderm, Triesence, Triloan Suik, Tritocin, Viaderm Kc, Xipere, Zilretta
Drug Type
Small Molecule
Chemical Formula
C21H27FO6
CAS Number
124-94-7
Unique Ingredient Identifier
1ZK20VI6TY
Background

Triamcinolone is a corticosteroid used to treat various inflammatory conditions in the body from allergic rhinitis to acute exacerbations of multiple sclerosis. Triamcinolone can be used as a one time adjunct treatment of osteoarthritic knee pain, or first line as a topical treatment of corticosteroid responsive dermatoses. Triamcinolone is more commonly seen in the forms triamcinolone hexacetonide, triamcinolone acetonide, and triamcinolone diacetate.

Triamcinolone was granted FDA approval on 3 December 1957. In October 2021, a suspension of triamcinolone acetonide was approved for suprachoroidal injection - the first suprachoroidal injection to receive FDA approval - for the treatment of patients with macular edema associated with uveitis.

Indication

肾上腺皮质激素类药。主要用于过敏性与自身免疫性炎症性疾病。由于本品潴钠作用较弱,故一般不用作肾上腺皮质功能减退的替代治疗。

Associated Conditions
Acne, Acne Vulgaris, Acute Gouty Arthritis, Allergic Contact Dermatitis, Allergic Rhinitis (AR), Allergic Skin Reaction, Alopecia Areata (AA), Ankylosing Spondylitis (AS), Aphthous Stomatitis, Asthma, Atopic Dermatitis, Autoimmune Hemolytic Anemia, Berylliosis, Bullous dermatitis herpetiformis, Chronic Eczema, Chronic Inflammatory Skin Diseases, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Contact Dermatitis, Crohn's Disease (CD), Dental Cavity, Dermatitis, Dermatomyositis (DM), Diaper Rash, Discoid Lupus Erythematosus (DLE), Edema of the cerebrum, Epicondylitis, Erythroderma, Fungal Infections, Fungal infectious disorders of the Beard, Fungal skin infection, Gingivitis, Haemorrhoids, Hemangiomas, Hypercalcemia, Inflammation of Mouth, Intertrigo, Itching of the Anus, Itching of the External Genitalia, Itching of the Foot, Itching of the genitals, Itching of the hand, Juvenile Idiopathic Arthritis (JIA), Keloids Scars, Leukemias, Lichen Planus (LP), Lichen simplex chronicus, Lymphoma, Macular Edema, Mycosis Fungoides (MF), Mycotic Eczema, Necrobiosis lipoidica diabeticorum, Neurodermatitis, Nummular Dermatitis, Ocular Inflammation, Ophthalmia, Sympathetic, Oral Erosive Lichen Planus, Otitis Externa, Pemphigus, Pericarditis, Polymyositis, Postherpetic Neuralgia, Primary adrenocortical insufficiency, Proteinuria, Psoriasis Vulgaris (Plaque Psoriasis), Psoriatic Arthritis, Psoriatic plaque, Pure Red Cell Aplasia, Purulent Wounds, Pyoderma caused by susceptible bacteria, Regional Enteritis, Rheumatoid Arthritis, Ringworm Folliculitis, Seborrheic Dermatitis, Seborrheic Dermatitis, Eczematous, Secondary Impetiginization, Secondary adrenocortical insufficiency, Secondary thrombocytopenia, Serum Sickness, Skin chapped, Stomatitis, Denture, Synovitis, Systemic Lupus Erythematosus, Temporal Arteritis, Tinea Corporis, Transfusion Reactions, Trichinosis, Tuberculosis (TB), Ulcerative Colitis, Urticaria, Uveitis, Wound Infections, Acute Bursitis, Acute Multiple sclerosis, Acute Rheumatic heart disease, unspecified, Acute Tenosynovitis, Corticosteroid-responsive dermatoses, Cutaneous candidiasis, Cystic tumour of the ganglia, Exfoliative erythroderma, Granuloma annulare lesions, Idiopathic eosinophilic pneumonias, Non-suppurative Thyroiditis, Oral infections, Oral lesions, Severe Erythema multiforme, Subacute Dermatitis, Eczematous, Symptomatic Sarcoidosis, Ulceration of the mouth, Ulcerative stomatitis

Trial Comparing Three Single Dose Injections for Knee Osteoarthritis

Phase 4
Terminated
Conditions
Osteoarthritis, Knee
Interventions
Drug: Monovisc 88 MG Per 4 ML Prefilled Syringe
Drug: Synvisc-One 48 MG in 6 ML Prefilled Syringe
First Posted Date
2022-08-09
Last Posted Date
2023-04-10
Lead Sponsor
Ohio State University
Target Recruit Count
6
Registration Number
NCT05492851
Locations
🇺🇸

Ohio State Outpatient Lewis Center, Lewis Center, Ohio, United States

🇺🇸

Jameson Crane Sports Medicine Institute, Columbus, Ohio, United States

Piezoelectric Drived Microneedling in Treating Refractory Skin Diseases

Not Applicable
Conditions
Keloid
Skin Tumor
Hypertrophic Scar
Skin Diseases
Warts
Plantar Wart
Interventions
First Posted Date
2022-08-05
Last Posted Date
2022-08-05
Lead Sponsor
Xiangya Hospital of Central South University
Target Recruit Count
20
Registration Number
NCT05488860
Locations
🇨🇳

Xiangya Hospital, Changsha, China

Suprachoroidal Triamcinolone Versus Posterior Subtenon Triamcinolone Alone or Formulated in the Management of Diabetic Macular Edema.

Not Applicable
Completed
Conditions
Diabetic Macular Edema of Left Eye
Interventions
First Posted Date
2022-07-19
Last Posted Date
2022-07-19
Lead Sponsor
Al-Azhar University
Target Recruit Count
75
Registration Number
NCT05464953
Locations
🇪🇬

Ehab tharwat, Damieta, New Damietta, Egypt

Pain Increases After Shoulder Injection

Phase 4
Completed
Conditions
Shoulder Pain
Interventions
First Posted Date
2022-06-29
Last Posted Date
2023-03-07
Lead Sponsor
Campbell Clinic
Target Recruit Count
421
Registration Number
NCT05438277
Locations
🇺🇸

Campbell Clinic, Germantown, Tennessee, United States

Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis

Phase 4
Active, not recruiting
Conditions
Atopic Dermatitis
Interventions
First Posted Date
2022-06-29
Last Posted Date
2025-05-14
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
433
Registration Number
NCT05436535
Locations
🇺🇸

University of California, San Diego: Dermatology Clinical Trials Unit, La Jolla, California, United States

🇺🇸

University of Pennsylvania, Perelman Center for Advanced Medicine: Department of Dermatology, Philadelphia, Pennsylvania, United States

🇺🇸

Children's Hospital Los Angeles: Division of Clinical Immunology & Allergy, Los Angeles, California, United States

and more 7 locations

Thyroid Associated Orbitopathy Treatment by Methotrexate Against Triamcinolone Periocular Injections

Phase 2
Completed
Conditions
Thyroid Associated Orbitopathy
Interventions
First Posted Date
2022-06-23
Last Posted Date
2022-09-21
Lead Sponsor
Cairo University
Target Recruit Count
18
Registration Number
NCT05429450
Locations
🇪🇬

Cairo University, Cairo, Egypt

Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes.

Phase 2
Completed
Conditions
Diabete Type 2
Cataract
Triamcinolone Acetonide
Intravitreal Injection
Interventions
First Posted Date
2022-06-10
Last Posted Date
2023-04-26
Lead Sponsor
Damascus University
Target Recruit Count
73
Registration Number
NCT05413330
Locations
🇸🇾

Damascus University, Damascus, Syrian Arab Republic

Intralesional Injection Of Methotrexate Versus Triamcinolone Acetonid In Treatment Of Localized Psoriasis

Not Applicable
Conditions
Localized Psoriasis
Interventions
Drug: Intralesional Injection of Methotrexate
First Posted Date
2022-06-07
Last Posted Date
2022-06-07
Lead Sponsor
Sohag University
Target Recruit Count
30
Registration Number
NCT05408208
Locations
🇪🇬

Sohag University, Sohag, Egypt

Comparison of the Analgesic Effect of 2 Shoulder Infiltrations

Not Applicable
Recruiting
Conditions
Infiltration
Shoulder Osteoarthritis
Interventions
First Posted Date
2022-06-07
Last Posted Date
2024-02-12
Lead Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Target Recruit Count
84
Registration Number
NCT05408065
Locations
🇨🇦

Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada

Formulated PSTA Injection Versus PATA Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein Occlusions

First Posted Date
2022-05-23
Last Posted Date
2022-05-26
Lead Sponsor
Al-Azhar University
Target Recruit Count
78
Registration Number
NCT05385562
Locations
🇪🇬

Ehab tharwat, Damieta, New Damietta, Egypt

© Copyright 2025. All Rights Reserved by MedPath